Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Barry Richard, Director. Insider active across 2 companies, notably Sarepta Therapeutics, Inc.. In total, 13 reports have been logged. Split: 5 buys · 0 sell. Total volume traded: €1.9m. History available since 7 March 2022. The latest transaction was filed on 22 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Richard Barry is a Board Member at Sarepta Therapeutics, Inc. He participates in overseeing the company's activities and making strategic decisions. Richard brings valuable experience in management and corporate governance.